GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Silo Wellness Inc (XCNQ:SILO) » Definitions » Total Receivables

Silo Wellness (XCNQ:SILO) Total Receivables : C$0.08 Mil (As of Jul. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Silo Wellness Total Receivables?

Silo Wellness's Total Receivables for the quarter that ended in Jul. 2023 was C$0.08 Mil.


Silo Wellness Total Receivables Historical Data

The historical data trend for Silo Wellness's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silo Wellness Total Receivables Chart

Silo Wellness Annual Data
Trend Oct20 Oct21 Oct22
Total Receivables
0.18 0.53 0.09

Silo Wellness Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.09 0.06 0.07 0.08

Silo Wellness Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


Silo Wellness Total Receivables Related Terms

Thank you for viewing the detailed overview of Silo Wellness's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Silo Wellness (XCNQ:SILO) Business Description

Traded in Other Exchanges
N/A
Address
200 Consumers Road, Suite 702, Toronto, ON, CAN, M2J 4R4
Silo Wellness Inc operates psychedelic clinics and develops legal functional mushroom consumer products. It is focused on health and wellness by developing and introducing psychedelic medicine to reduce trauma and increase performance by destigmatizing the active compounds in psychedelics and innovating ease of administration and ingestion.
Executives
Michael Hartman Director